Feb 22, 2019 - NuVasive (NUVA) reports growth in revenues across all key operating segments in the fourth quarter of 2018.
Feb 21, 2019 - Genomic Health's (GHDX) year-over-year rise in revenues, driven by a solid uptick in the United States and internationally, makes us optimistic about the stock.
Feb 20, 2019 - CVS Health's (CVS) recently introduced Health Care Benefits segment following the Aetna acquisition holds immense promise.
Feb 14, 2019 - CONMED's (CNMD) guidance for 2019 buoys optimism in the stock.
Feb 14, 2019 - DaVita's (DVA) Q4 results gain from increasing dialysis services in and outside the United States.
Feb 12, 2019 - STERIS (STE) continues to gain from strength in all business segments in Q3.
Feb 08, 2019 - Omnicell (OMCL) steadily benefits from product introductions, strategic alliances and digital conversions.
Feb 07, 2019 - Cardinal Health's (CAH) Q2 results benefit from strong sales in the Pharmaceutical segment. An upbeat guidance is indicative of brighter prospects.
Feb 06, 2019 - Cerner (CERN) gains from solid segmental revenues in fourth-quarter 2018. However, the company's 2019 guidance disappoints.
Feb 04, 2019 - Omnicell (OMCL) gains from expanding into new markets. Stiff rivalry is a concern.